Abstract
Anticonflict-like effects of the mGlu5 receptor antagonist MTEP (systemic administrations: 1.50, 3.0 or 6.0 mg/kg; i.p.; intra-lateral septal nuclei or intra-medial septal region infusions: 2.5 μg/μl, 5.0 μg/μl or 10.0 μg/μl) were assessed in Wistar rats during late proestrus or metestrus–diestrus. Results showed that control rats displayed an increased number of immediately punished reinforcers during late proestrus ( P < 0.05), when compared to metestrus–diestrus. During late proestrus, systemic administrations (3.0 mg/kg, P < 0.05; 6.0 mg/kg P < 0.05) or intra-lateral septal nuclei infusions (5.0 μg/μl, P < 0.05; 10.0 μg/μl, P < 0.05) of MTEP increased the number of immediately punished reinforcers received. During metestrus–diestrus only the highest doses of MTEP (systemic administration: 6.0 mg/kg P < 0.05; intra-lateral septal nuclei infusions: 10.0 μg/μl, P < 0.05) increased the number of immediately punished reinforcers obtained. MTEP infusions into the medial septum produced neither of these anticonflict effects. In conclusion, data showed an estrus variation in those anticonflict-like effects of the mGlu5 receptor antagonist MTEP, systemically administered or microinjected into lateral septal nuclei of female Wistar rats.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
